MedTrace Logo

Phenotyping of Chronic Pain in Diffused Systemic Scleroderma

NCT05622578 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-12-04

No results posted yet for this study

Summary

The primary objective of the study is to describe the different phenotyping of pain in systemic scleroderma patients and perturbations of mechanisms of the pain.

As secondary objectives, the study aims to describe the importances of overall symptoms in alteration of quality of life and conserve the questions which will be associated in a unique questionnaire in order to evaluate the pain, the fatigue and the sleeping disorders in diffused systemic scleroderma patients.

Conditions

  • Scleroderma, Systemic
  • Scleroderma, Diffuse

Interventions

OTHER

QST, CPM and Paisudoscan

Quantified pain tests

Sponsors & Collaborators

  • Association de patients : association sclérodermies de France

    collaborator UNKNOWN

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Serge PERROT, MD, PhD · Center of evaluation and treatment of pain - Cochin hospital - APHP

  • Anne Priscille TROUVIN, MD · Center of evaluation and treatment of pain - Cochin hospital - APHP

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-19
Primary Completion
2023-12-19
Completion
2024-10-04

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05622578 on ClinicalTrials.gov